tiprankstipranks
Alcon Inc (IT:1ALC)
:1ALC
Italy Market
1ALC
Alcon
RESEARCH TOOLSreports

Alcon (1ALC) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

1ALC Analyst Ratings

Moderate Buy
11Ratings
Moderate Buy
7 Buy
3 Hold
1 Sell
Based on 11 analysts giving stock ratings to
Alcon
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1ALC Stock 12 Month Forecast

Average Price Target

€75.66
▲(25.22% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Alcon in the last 3 months. The average price target is €75.66 with a high forecast of €90.50 and a low forecast of €51.11. The average price target represents a 25.22% change from the last price of €60.42.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"50":"€50","91":"€91","60.25":"€60.3","70.5":"€70.5","80.75":"€80.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":90.504515,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€90.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":75.656107415,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€75.66</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":51.108432,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€51.11</span>\n  </div></div>","useHTML":true}}],"tickPositions":[50,60.25,70.5,80.75,91],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,59.48,61.86650115384615,64.2530023076923,66.63950346153845,69.02600461538461,71.41250576923076,73.79900692307692,76.18550807692307,78.57200923076923,80.95851038461538,83.34501153846153,85.73151269230769,88.11801384615384,{"y":90.504515,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,59.48,60.724315954999994,61.96863191,63.212947865,64.45726382,65.701579775,66.94589572999999,68.190211685,69.43452764,70.67884359499999,71.92315955,73.167475505,74.41179145999999,{"y":75.656107415,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,59.48,58.836033230769225,58.19206646153846,57.54809969230769,56.90413292307692,56.26016615384615,55.616199384615385,54.97223261538461,54.32826584615385,53.684299076923075,53.04033230769231,52.39636553846154,51.75239876923077,{"y":51.108432,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":75.135,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.169,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.193,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.696,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.672,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.672,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.179,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.657,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.686,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.074,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.54,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.34,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.48,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€90.50Average Price Target€75.66Lowest Price Target€51.11
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on IT:1ALC
Graham Doyle
UBS
UBS
€91.57→€88.37
Buy
46.27%
Upside
Reiterated
08/14/26
Analysts' Top Healthcare Picks: Alcon (ALC), Kuros Biosciences (CSBTF)
Mizuho Securities Analyst forecast on IT:1ALC
Anthony Petrone
Mizuho Securities
Mizuho Securities
€73.69
Buy
21.96%
Upside
Reiterated
08/13/26
Analysts Offer Insights on Healthcare Companies: Spruce Biosciences (NASDAQ: SPRB) and Alcon (NYSE: ALC)
William Blair Analyst forecast on IT:1ALC
Steven Lichtman
William Blair
William Blair
―
Hold
―
Assigned
08/12/26
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT) and Alcon (NYSE: ALC)
J.P. Morgan Analyst forecast on IT:1ALC
David Adlington
J.P. Morgan
J.P. Morgan
€67.97
Hold
12.49%
Upside
Reiterated
08/12/26
J.P. Morgan Sticks to Their Hold Rating for Alcon (ALC)
Needham Analyst forecast on IT:1ALC
David Saxon
Needham
Needham
€82.36→€84.96
Buy
40.61%
Upside
Reiterated
08/11/26
Analyst Reiterates Buy on Alcon After Q2 Beat, Raised Earnings Outlook, and Strengthening Multi-Pillar Growth Drivers
Berenberg Bank Analyst forecast on IT:1ALC
Sam England
Berenberg Bank
Berenberg Bank
€90.5
Buy
49.79%
Upside
Reiterated
08/07/26
Berenberg Bank Keeps Their Buy Rating on Alcon (ALC)
Bank of America Securities Analyst forecast on IT:1ALC
Julien Ouaddour
Bank of America Securities
Bank of America Securities
€53.24→€51.11
Sell
-15.41%
Downside
Reiterated
07/21/26
Alcon Cut to Sell as Underperformance, Competitive Pressure and Softer Markets Drive Price Target Reduction from CHF50 to CHF48
Argus Research Analyst forecast on IT:1ALC
Jasper Hellweg
Argus Research
Argus Research
€73.69
Buy
21.96%
Upside
Reiterated
07/01/26
Alcon price target lowered to $85 from $90 at ArgusAlcon price target lowered to $85 from $90 at Argus
KeyBanc Analyst forecast on IT:1ALC
Brett Fishbin
KeyBanc
KeyBanc
€76.29
Buy
26.27%
Upside
Reiterated
06/12/26
Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (NYSE: EVMN), Immunome (NASDAQ: IMNM) and Alcon (NYSE: ALC)
Citi Analyst forecast on IT:1ALC
Veronika Dubajova
Citi
Citi
€97.1→€89.29
Buy
47.79%
Upside
Reiterated
06/11/26
Alcon (ALC) Gets a Buy from Citi
Stifel Nicolaus Analyst forecast on IT:1ALC
Thomas Stephan
Stifel Nicolaus
Stifel Nicolaus
€60.69
Hold
0.44%
Upside
Reiterated
05/21/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Alcon (NYSE: ALC) and Oruka Therapeutics (NASDAQ: ORKA)
Deutsche Bank Analyst forecast on IT:1ALC
Falko Friedrichs
Deutsche Bank
Deutsche Bank
€81.99→€74.53
Buy
23.36%
Upside
Reiterated
05/12/26
Alcon price target lowered to CHF 70 from CHF 77 at Deutsche BankAlcon price target lowered to CHF 70 from CHF 77 at Deutsche Bank
Robert W. Baird Analyst forecast on IT:1ALC
Jeff Johnson
Robert W. Baird
Robert W. Baird
€84.96→€78.02
Buy
29.14%
Upside
Reiterated
05/07/26
Alcon price target lowered to $90 from $98 at BairdAlcon price target lowered to $90 from $98 at Baird
Barclays Analyst forecast on IT:1ALC
Matt Miksic
Barclays
Barclays
€67.62
Hold
11.92%
Upside
Reiterated
05/06/26
Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (NASDAQ: ACAD), Qiagen (NYSE: QGEN) and Alcon (NYSE: ALC)
RBC Capital Analyst forecast on IT:1ALC
Jack Reynolds-Clark
RBC Capital
RBC Capital
€85.18
Buy
40.98%
Upside
Reiterated
05/06/26
Alcon (ALC) Gets a Buy from RBC Capital
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on IT:1ALC
Graham Doyle
UBS
UBS
€91.57→€88.37
Buy
46.27%
Upside
Reiterated
08/14/26
Analysts' Top Healthcare Picks: Alcon (ALC), Kuros Biosciences (CSBTF)
Mizuho Securities Analyst forecast on IT:1ALC
Anthony Petrone
Mizuho Securities
Mizuho Securities
€73.69
Buy
21.96%
Upside
Reiterated
08/13/26
Analysts Offer Insights on Healthcare Companies: Spruce Biosciences (NASDAQ: SPRB) and Alcon (NYSE: ALC)
William Blair Analyst forecast on IT:1ALC
Steven Lichtman
William Blair
William Blair
―
Hold
―
Assigned
08/12/26
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT) and Alcon (NYSE: ALC)
J.P. Morgan Analyst forecast on IT:1ALC
David Adlington
J.P. Morgan
J.P. Morgan
€67.97
Hold
12.49%
Upside
Reiterated
08/12/26
J.P. Morgan Sticks to Their Hold Rating for Alcon (ALC)
Needham Analyst forecast on IT:1ALC
David Saxon
Needham
Needham
€82.36→€84.96
Buy
40.61%
Upside
Reiterated
08/11/26
Analyst Reiterates Buy on Alcon After Q2 Beat, Raised Earnings Outlook, and Strengthening Multi-Pillar Growth Drivers
Berenberg Bank Analyst forecast on IT:1ALC
Sam England
Berenberg Bank
Berenberg Bank
€90.5
Buy
49.79%
Upside
Reiterated
08/07/26
Berenberg Bank Keeps Their Buy Rating on Alcon (ALC)
Bank of America Securities Analyst forecast on IT:1ALC
Julien Ouaddour
Bank of America Securities
Bank of America Securities
€53.24→€51.11
Sell
-15.41%
Downside
Reiterated
07/21/26
Alcon Cut to Sell as Underperformance, Competitive Pressure and Softer Markets Drive Price Target Reduction from CHF50 to CHF48
Argus Research Analyst forecast on IT:1ALC
Jasper Hellweg
Argus Research
Argus Research
€73.69
Buy
21.96%
Upside
Reiterated
07/01/26
Alcon price target lowered to $85 from $90 at ArgusAlcon price target lowered to $85 from $90 at Argus
KeyBanc Analyst forecast on IT:1ALC
Brett Fishbin
KeyBanc
KeyBanc
€76.29
Buy
26.27%
Upside
Reiterated
06/12/26
Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (NYSE: EVMN), Immunome (NASDAQ: IMNM) and Alcon (NYSE: ALC)
Citi Analyst forecast on IT:1ALC
Veronika Dubajova
Citi
Citi
€97.1→€89.29
Buy
47.79%
Upside
Reiterated
06/11/26
Alcon (ALC) Gets a Buy from Citi
Stifel Nicolaus Analyst forecast on IT:1ALC
Thomas Stephan
Stifel Nicolaus
Stifel Nicolaus
€60.69
Hold
0.44%
Upside
Reiterated
05/21/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Alcon (NYSE: ALC) and Oruka Therapeutics (NASDAQ: ORKA)
Deutsche Bank Analyst forecast on IT:1ALC
Falko Friedrichs
Deutsche Bank
Deutsche Bank
€81.99→€74.53
Buy
23.36%
Upside
Reiterated
05/12/26
Alcon price target lowered to CHF 70 from CHF 77 at Deutsche BankAlcon price target lowered to CHF 70 from CHF 77 at Deutsche Bank
Robert W. Baird Analyst forecast on IT:1ALC
Jeff Johnson
Robert W. Baird
Robert W. Baird
€84.96→€78.02
Buy
29.14%
Upside
Reiterated
05/07/26
Alcon price target lowered to $90 from $98 at BairdAlcon price target lowered to $90 from $98 at Baird
Barclays Analyst forecast on IT:1ALC
Matt Miksic
Barclays
Barclays
€67.62
Hold
11.92%
Upside
Reiterated
05/06/26
Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (NASDAQ: ACAD), Qiagen (NYSE: QGEN) and Alcon (NYSE: ALC)
RBC Capital Analyst forecast on IT:1ALC
Jack Reynolds-Clark
RBC Capital
RBC Capital
€85.18
Buy
40.98%
Upside
Reiterated
05/06/26
Alcon (ALC) Gets a Buy from RBC Capital
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
JBIOJade Biosciences
GHRSGH Research
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alcon

3 Months
Larry BiegelsenWells Fargo
Success Rate
13/19 ratings generated profit
68%
Average Return
+2.04%
Copying Larry Biegelsen's trades and holding each position for 3 Months would result in 68.42% of your transactions generating a profit, with an average return of +2.04% per trade.
1 Year
Larry BiegelsenWells Fargo
Success Rate
12/19 ratings generated profit
63%
Average Return
+4.57%
Copying Larry Biegelsen's trades and holding each position for 1 Year would result in 63.16% of your transactions generating a profit, with an average return of +4.57% per trade.
2 Years
Anthony PetroneMizuho Securities
Success Rate
13/24 ratings generated profit
54%
Average Return
+4.36%
Copying Anthony Petrone's trades and holding each position for 2 Years would result in 54.17% of your transactions generating a profit, with an average return of +4.36% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1ALC Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
3
4
5
2
Buy
18
15
8
7
7
Hold
5
7
5
4
2
Sell
3
3
2
2
1
Strong Sell
0
0
0
0
0
total
26
28
19
18
12
In the current month, 1ALC has received 9 Buy Ratings, 2 Hold Ratings, and 1 Sell Ratings. 1ALC average Analyst price target in the past 3 months is 75.66.
Each month's total comprises the sum of three months' worth of ratings.

1ALC Financial Forecast

1ALC Earnings Forecast

Next quarter’s earnings estimate for 1ALC is €0.76 with a range of €0.72 to €0.79. The previous quarter’s EPS was €0.72. 1ALC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1ALC has Performed in-line its overall industry.
Next quarter’s earnings estimate for 1ALC is €0.76 with a range of €0.72 to €0.79. The previous quarter’s EPS was €0.72. 1ALC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1ALC has Performed in-line its overall industry.

1ALC Sales Forecast

Next quarter’s sales forecast for 1ALC is €2.36B with a range of €2.34B to €2.39B. The previous quarter’s sales results were €2.37B. 1ALC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1ALC has Performed in-line its overall industry.
Next quarter’s sales forecast for 1ALC is €2.36B with a range of €2.34B to €2.39B. The previous quarter’s sales results were €2.37B. 1ALC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1ALC has Performed in-line its overall industry.

1ALC Stock Forecast FAQ

What is IT:1ALC’s average 12-month price target, according to analysts?
Based on analyst ratings, Alcon Inc’s 12-month average price target is 75.66.
    What is IT:1ALC’s upside potential, based on the analysts’ average price target?
    Alcon Inc has 25.22% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Alcon Inc a Buy, Sell or Hold?
          Alcon Inc has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 3 hold ratings and 1 sell ratings.
            What is Alcon Inc’s share price target?
            The average share price target for Alcon Inc is 75.66. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €90.50 ,and the lowest forecast is €51.11. The average share price target represents 25.22% Increase from the current price of €60.42.
              What do analysts say about Alcon Inc?
              Alcon Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of Alcon Inc?
                To buy shares of IT:1ALC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.